Daewoong Pharmaceutical is set to supply digital healthcare diagnostic devices to primary care health check-up centers through a business agreement with the Korean Health Checkup Institutions Association (KHCIA), aiming to enhance the quality of health check-up services. Both parties held a signing ceremony on the 27th at Daewoong Pharmaceutical’s headquarters in Seoul, deciding to pursue innovations in health check-up services and joint social contribution projects.
Under this agreement, Daewoong Pharmaceutical will provide the latest digital healthcare devices such as the wearable ECG device ‘Mobicare’, ring-type blood pressure monitor ‘CartBP’, AI blindness disease diagnostic support solution ‘Whiskey’, fundus camera ‘Optina Genesis’, and continuous glucose monitor ‘Freestyle Libre’ to KHCIA-affiliated institutions. This will enable precise examinations at primary care medical institutions and is expected to improve the accuracy and accessibility of health check-ups.
Conventional health check-ups often had limitations in the reliability of test results due to environmental factors such as fasting, lack of sleep, and psychological stress. The continuous digital measuring devices supplied by Daewoong Pharmaceutical collect data under everyday conditions, providing more accurate diagnostic information. These devices are already being utilized in outpatient treatment settings and are observed as potential health check-up standards in the future.
Daewoong Pharmaceutical and KHCIA will also collaborate on expert consultation and field validation of new products. Through this cooperation, they aim to enhance product development reliability and provide solutions suitable for actual check-up environments to the market. Additionally, they plan to work together on volunteering activities to reduce medical blind spots, with Daewoong Pharmaceutical providing examination equipment and consumables and KHCIA handling medical personnel and operations to offer free check-ups for public institutions and local residents.
Daewoong Pharmaceutical’s CEO, Lee Chang-jae, stated, “Through this business agreement, we will actively expand the latest digital health check-up solutions, primarily used in university hospital exams, into the primary check-up area, allowing more citizens to receive precise check-ups closer and more conveniently, leading healthy lives, through close collaboration with KHCIA.”